baber/WOPTO huggingface dataset:
Patent AT-E380394-T1 (AT)
Inventor: BHAKTA JAYESH
IPC: H01R13/08
Filed: 1999-01-19
Granted: 2007-12-15
Abstract: A module for insertion into an expansion slot of a computer includes a primary board and a pair of auxiliary boards. The auxiliary boards are mounted in a spaced relationship on respective sides of the primary board to define air paths between the boards. The air paths allow air to circulate between the boards. The auxiliary boards each have a trace for electrically connecting the board to the primary board, and the primary board has a trace for connecting chips mounted thereon to an interface with the expansion slot. The traces of the auxiliary boards are substantially the same length. The trace of the primary boards is only slightly longer than the traces of the auxiliary boards.
Patent AT-E243674-T1 (AT)
Inventor: WATZENBERGER OTTO
IPC: B01J39/04
Filed: 1999-02-16
Granted: 2003-07-15
Abstract: The present invention relates to a process for the preparation of an aqueous hydroxylamine solution which is essentially free of metal ions, wherein the hydroxylamine solution is subjected to at least one treatment with an acidic cation exchanger.
Patent AT-E245434-T1 (AT)
Inventor: KHAVINSON VLADIMIR KHATSKELEVI
IPC: A61K38/00
Filed: 1999-05-27
Granted: 2003-08-15
Abstract: L-Lys-L-Glu dipeptide is proposed for use in medicine for preparation of a drug capable of stimulating repair processes. According to the invention, the pharmaceutical peptide preparation capable of stimulating regeneration consists of pharmaceutically admissible carrier and effective quantity of dipeptide as an active part, which is a combination of, L-lysil-L-glutamic acid or its salts.The pharmaceutical peptide preparation is proposed for parenteral, intranasal oral and local application.According to the invention, the method stimulating regeneration consists of prophylactic and/or treatment injections of the drug in the dose of 0.01-100 mukg per per 1 kg of weight, at least once a day during a period necessary for obtaining a therapeutic effect.
Patent AT-E359909-T1 (AT)
Inventor: BERTRAM RICHARD L
IPC: B32B27/04
Filed: 1999-06-11
Granted: 2007-05-15
Abstract: A composite, chemically integrated material structure bearing load around a close-loop structural configuration in cross-section, has a plurality of regions through the cross-sectional thickness imparting at selectively predetermined locations within the cross-section, high tensile strength and high compressive strength. A method for forming such an integrated, composite material structure onto and incorporating an established or pre-existing, but likely deteriorated, concrete or brick structure, while achieving precise, predetermined resulting interior diameter and other structural dimensions is described.
Patent AT-E373455-T1 (AT)
Inventor: FEINGOLD VLADIMIR
IPC: A61B17/32
Filed: 1999-08-11
Granted: 2007-10-15
Abstract: A blade assembly for a keratome is suspended from its ends by a blade support which is driven by a drive mechanism, so that the blade describes a forward path between a positioning ring and an applanation shoe at a controlled distance from the applanation shoe reference surface while also oscillating laterally, and preferably without the blade or the blade support touching either the positioning ring or the applanation shoe. A guide may be disposed parallel to the blade edge to control resectioning thickness. Drive control and vacuum for the positioning ring are provided under user command by a control unit having user inputs. <IMAGE>
Patent AT-E411394-T1 (AT)
Inventor: FELDSINE PHILIP
IPC: C12M1/34
Filed: 1999-08-13
Granted: 2008-10-15
Abstract: Compositions, formulae, devices and methods for the detection of target microorganisms, such as by visual immunoprecipitate assay, enzyme linked immunoassay, chemiluminescence, immunoblotting, or similar detection technology, wherein detection requires the discrimination among closely related genera, species and strains of antigenically related microorganisms based on immunological reactivity of a highly conserved antigen epitopes with a reagent system comprised of an antibody linked to a detecting reagent. The invention permits a detectable event to occur by exposing inaccessible but highly conserved and specific antigen epitopes to the detecting reagent. Exposure of such antigen epitopes without inactivating microbial metabolism allows for specific detection.
Patent AT-E230425-T1 (AT)
Inventor: GOERRISSEN HEINER
IPC: B29C51/08
Filed: 1999-08-20
Granted: 2003-01-15
Abstract: The thermoplastic molding compositions proposed compriseA) from 20 to 90% by weight, preferably from 30 to 80% by weight, particularly preferably from 40 to 75% by weight, of a thermoplastic polymer, andB) from 10 to 80% by weight, preferably from 20 to 70% by weight, particularly preferably from 25 to 60% by weight, of a crosslinked rubber having two or more phases,where the polymer A has a viscosity number, measured on a 0.5% strength solution in dimethylformamide at 23° C., of from 50 to 70 ml/g, preferably from 55 to 65 ml/g, and where at least 80% by number, preferably at least 85% by number, particularly preferably at least 90% by number, of the rubber particles B in the dispersion, after the preparation thereof, have a diameter of <0.2 mum, preferably <0.18 mum, particularly preferably <0.15 MUM.
Patent AT-E244868-T1 (AT)
Inventor: SAXBY MICHAEL ERNEST
IPC: F42B8/04
Filed: 1999-09-14
Granted: 2003-07-15
Abstract: The invention provides a blank pyrotechnic cartridge comprising a cartridge casing having a bullet-like projection extending forwardly therefrom, the bullet-like projection being retractable through an opening in the casing when the cartridge is fired, the cartridge being axially expandable in a rearwards direction in use to move the breechblock of a firearm to recycle the firearm.Also provided is a method of feeding blank ammunition into the barrel of a gun comprising the step of loading the gun with a blank cartridge, the blank cartridge comprising a cartridge casing having a bullet-like projection extending forwardly therefrom, the bullet-like projection being retractable through an opening in the casing when the cartridge is fired, the cartridge being axially expandable in a rearwards direction in use to move a breechblock of the gun to recycle the gun.
Patent AT-E291607-T1 (AT)
Inventor: GORNOWICZ GERALD A
IPC: C08J3/24
Filed: 1999-09-13
Granted: 2005-04-15
Abstract: There is disclosed a method for preparing a thermoplastic elastomer composition which exhibits improved mechanical properties, said method comprising: (I) reacting, (A) a fluorocarbon resin with, (B) a grafting agent, in the presence of, (C) a radical initiator, to prepare a modified fluorocarbon resin; (II) mixing said modified fluorocarbon resin with (D) a silicone base consisting essentially of a diorganopolysiloxane gum having an average of at least 2 alkenyl radicals in its molecule and a reinforcing filler, (E) an organohydrido silicon compound which contains an average of a t least 2 silicon-bonded hydrogen groups in its molecule, and (F) a hydrosilation catalyst, components (E) and (F) being present in an amount sufficient to cure said diorganopolysiloxane; and dynamically curing said diorganopolysiloxane.
Patent AT-E313224-T1 (AT)
Inventor: FRIMAN LEIF
IPC: H04L12/28
Filed: 1999-10-13
Granted: 2005-12-15
Abstract: The present invention relates to a mobile system, which includes a base station controller and at least a first and a second base station, which comprise switching means for switching transceiver units of the base stations onto a particular channel of a plurality of optional telecommunication channels between the base station controller and the base stations. In order for the telecommunication channels to be utilized efficiently, the base station controller comprises control means, which allocate in connection with call set-up at least one of said telecommunication channels to the first or to the second base station for the duration of the call, and which transmit a predetermined message on the allocated channel to the base station to which the channel is allocated, the switching means of the first and, correspondingly, of the second base stations being responsive to said message for switching the transceiver units to the channel assigned by said message.
Patent AT-E285769-T1 (AT)
Inventor: JENSEN BO
IPC: A61K31/404
Filed: 1999-12-03
Granted: 2005-01-15
Abstract: The present invention relates to ion channel activating agents. More particularly, the present invention relates to a particular class of chemical compounds that has proven useful as openers of SKCa and IKCa channels. In further aspects, the present invention relates to the use of these SK/IK channel activating agents for the manufacture of medicaments and pharmaceutical compositions comprising the SK/IK channel activating agents. The SK/IK channel activating agents of the invention are useful for the treatment or alleviation of diseases and conditions associated with the SK/IK channels, in particular respiratory diseases such as asthma, cystic fibrosis, chronic obstructive pulmonary disease and rhinorrhea, convulsions, vascular spasms, coronary artery spasms, renal disorders, polycystic kidney disease, bladder spasms, urinary incontinence, bladder outflow obstruction, irritable bowel syndrome, gastrointestinal dysfunction, secretory diarrhea, ischaemia, cerebral ischaemia, ischaemic heart disease, angina pectoris, coronary heart disease, traumatic brain injury, psychosis, anxiety, depression, dementia, memory and attention deficits, Alzheimer's disease, dysmenorrhea, narcolepsy, Reynaud's disease, intermittent claudication, Sjorgren's syndrome, migraine, arrhythmia, hypertension, absence seizures, myotonic muscle dystrophia, xerostomi, diabetes type II, hyperinsulinemia, premature labor, baldness, cancer, and immune suppression.
Patent AT-E500561-T1 (AT)
Inventor: SMYTHE MARK
IPC: G01N33/50
Filed: 1999-10-21
Granted: 2011-03-15
Abstract: A method of protein engineering is provided wherein a searchable computer database is created comprising entries in the form of descriptions of a location and orientation in 3D space of side chains of the constituent amino acid residues of a framework protein. A query is created which corresponds to a description of a location and orientation in 3D space of respective side chains of amino acid residues of a sample protein. The location and orientation in 3D space of constituent side-chains is preferably described as a Calpha Cbeta vector. The query is used to search the database and thereby identify a hit which corresponds to a framework protein having structural similarity with said sample protein. Framework protein "hits" so identified may be suitable candidates for further modification. A particular advantage of the present invention is that a modified framework protein may display one or more desired characteristics, such as a function similar to or inhibitory of the sample protein.
Patent DE-04735990-T1 (DE)
Title: Sprachsynthesevorrichtung, sprachsyntheseverfahren und programm
Inventor: SATO YASUSHI
IPC: G10L13/027
Filed: 2004-06-03
Abstract: Eine
Sprachsynthesevorrichtung, die dadurch gekennzeichnet ist, dass
die Vorrichtung Folgendes umfasst:  ein Stimmeinheitsspeicherungsmittel,
das eine Vielzahl von Stimmeinheitsdaten speichert, die eine Stimmeinheit repräsentieren;  ein
Auswahlmittel, das Satzinformationen, die einen Satz repräsentieren,
eingibt und Stimmeinheitsdaten auswählt, deren Lesung einem Sprachlaut
gemein ist, das den Satz aus den jeweiligen Stimmeinheitsdaten umfasst;  ein
Versäumnisstücksynthesemittel,
das für
einen Sprachlaut unter den Sprachlauten, die den Satz umfassen,
für den
das Auswahlmittel keine Stimmeinheitsdaten auswählen konnten, Sprachdaten synthetisiert,
die eine Wellenform des Sprachlauts repräsentieren; und  ein Synthesemittel,
das synthetische Sprache repräsentierende
Daten durch Kombinieren von Stimmeinheitsdaten, die vom Auswahlmittel
ausgewählt
wurden, und Sprachdaten, die vom Versäumnisstücksynthesemittel synthetisiert wurden,
generiert.
Patent DE-19877815-T1 (DE)
Title: Temperaturisolierte verpackungssysteme und zugehörige verfahren
Inventor: MADANAGOPAL ARUNKUMAR
IPC: B65D65/46
Filed: 2019-11-01
Abstract: Temperaturisoliertes Verpackungssystem, wobei das Verpackungssystem umfasst:einen Behälter mit einer Innenfläche, die ein Innenvolumen begrenzt; undeine Auskleidung, die innerhalb des Innenvolumens des Behälters angeordnet ist und mindestens teilweise ein Fach begrenzt, das dazu konfiguriert ist, einen Versandartikel aufzunehmen, wobei die Auskleidung umfasst:eine erste Hülle, die aus einem ersten Zellulosematerial besteht und mindestens teilweise einen Kanal begrenzt, wobei die erste Hülle eine Außenwand, die in Richtung des Behälters angeordnet ist, und eine gegenüberliegende Innenwand aufweist, die in Richtung des Fachs angeordnet ist, das so konfiguriert ist, dass es den Versandartikel aufnimmt, wobei der Kanal zwischen der Innenwand und der Außenwand angeordnet ist; undmindestens eine Isolierbahn, die in dem Kanal der ersten Hülle angeordnet ist, wobei die mindestens eine Isolierbahn aus einem zweiten Zellulosematerial besteht und eine Vielzahl von darauf ausgebildeten Vertiefungen aufweist.
Patent DE-856320-T1 (DE)
Inventor: BRYANT ROBERT J
IPC: A61M5/142
Filed: 1994-02-28
Abstract: Pumping mechanisms for performing peritoneal dialysis and the like employ a pumping mechanism comprising a diaphragm (59) that operate in response to applied fluid pressure. Flexible tubing is attached to the pumping mechanism for carrying liquid to and from the patient's peritoneal cavity. An actuating station for pumping mechanism receives the pumping mechanism, and attached tubing. A pressure transfer element (104) conveys fluid pressure to the diaphragm (59) for moving liquid through the cassette. An occluder element (138,144) contacts and crimps closed the tubing attached to the cassette. A first reservoir (128) inflates with positive fluid pressure for contacting the pressure transfer element (104) to hold it in operative contact against the diaphragm (59). A second reservoir inflates with positive fluid pressure for contacting the occluding element (138,144) to hold it away from crimping contact with the tubing. At least one of the first (128) and second (152) reservoirs also transports fluid pressure to the pressure transfer element for conveyance to the diaphragm.
Patent ES-2189704-T1 (ES)
Title: Dispositivo de fijacion de las crucetas de un parachoques.
Inventor: DEVILLIERS OLIVIER
IPC: B60R19/24
Filed: 2001-02-02
Abstract: Dispositivo de fijación de las crucetas de un parachoques en la parte inferior de los guardabarros de un vehículo, que comprende: - en la parte superior de las crucetas (1) del parachoques, un reborde (5) sensiblemente horizontal que se extiende hacia el interior del vehículo, - en la parte inferior del guardabarros (2, 2¿), un borde entrante (7, 7¿) sensiblemente horizontal y una superficie de apoyo situada debajo de este borde entrante y que tiene como función soportar el reborde (5) del parachoques para mantenerlo cerca de dicho borde entrante, - en el reborde y en el borde, unas formas complementarias (13, 14) aptas para engatillarse para inmovilizar el parachoques en la posición deseada con respecto al guardabarros, caracterizado porque la superficie de apoyo está constituida por una sucesión de apoyos discretos (12) repartidos a lo largo del borde, estando localizadas las formas complementarias (13, 14) fuera de estos apoyos discretos, siendo el reborde del parachoques apto para deformarse elásticamente entre dos apoyos discretos para permitir, gracias solamente a su deformación, el engatillado de las formas complementarias.
Patent ES-2088376-T1 (ES)
Inventor: MOGILNICKI VICTOR D
IPC: B23B31/20
Filed: 1994-07-11
Abstract: A collet is designed for a tool having a cylindrical shank and a square drive at the rearward end of the cylindrical shank. The collet includes a collet body having a plurality of radially compressible collet segments. An axial bore is formed in the collet body for receiving the cylindrical shank of the tool. The tool is secured in the axial bore by collapsing the collet segments around the cylindrical shank of the tool. A grip-forming slot extends through a midsection of the collet body and communicates with the axial bore so as to receive the square drive of the tool when the tool is inserted into the axial bore. A pair of gripping surfaces are formed on respective collet segments on opposite sides of the grip-forming slot for gripping opposed surfaces of the square drive when the collet segments are radially collapsed to prevent radial movement of the tool.
Patent CY-1107957-T1 (CY)
Inventor: WOBBEN ALOYS
IPC: E01D11/02
Filed: 2008-05-23
Abstract: Offshore wind power installations usually require a landing stage or landing pier so that craft, in particular ships, can guarantee supply and transportation services. In the case of small offshore installations, these are usually simple jetties with possible ways of making boats fast. In the case of larger offshore installations at which larger supply ships land, the landing installations are of a more expensive and complicated structure and have for example supply intermediate storage facilities such as fuel tanks and loading equipment such as cranes.
Patent CY-1110459-T1 (CY)
Inventor: DALTON JAMES
IPC: C07C237/14
Filed: 2009-05-08
Abstract: Selective androgen receptor modulator propanamide derivatives (I) are new. Selective androgen receptor modulator propanamide derivatives of formula (I) are new. X : O, CH 2, NH, Se, PR or NR; Z : NO 2, CN, COR, COOH or CONHR; Y : I, CF 3, Br, Cl or SnR 3; Q : alkyl, H, NR 2, NHCOCH 3, NHCOCF 3, NHCOR, NHCONHR, NHCCOR, OCONHR, CONHR, NHCSCH 3, NHCSCF 3, NHCSR, NHSO 2CH 3, NHSO 2R, OR, COR, OCOR, OSO 2R, SO 2R or SR; or Q : a fused ring of formula (i)-(iii); R : alkyl, aryl, 1-4C (halo)alkyl, phenyl, halo, alkenyl or OH; R 1 : CH 3, CF 3, CH 2CH 3or CF 2CF 3; and T : OH, OR, NHCOCH 3or NHCOR. Independent claims are included for: (1) a method of modulating spermatogenesis comprising administration of (I); (2) a method of hormone therapy comprising administration of (I); (3) a method of treating hormone related conditions comprising administration of (I); and (4) a method of treating prostate cancer comprising administration of (I). [Image] [Image] ACTIVITY : Cytostatic. MECHANISM OF ACTION : Androgen receptor modulator. In vitroactivity of the selective androgen receptor modulator compounds (I) was determined. N-[4-nitro-3-trifluoromethyl)-phenyl]-(2S)-3-[4-(acetylamino)-phenoxy]-2-hydroxy-2-methylpropanamide (Ia) bound to the androgen receptor with a K ivalue of 7.5 nM.
Patent CY-1110257-T1 (CY)
Inventor: KASTNER FRIEDRICH
IPC: B65D81/34
Filed: 2009-06-03
Abstract: Packaging for heating in a microwave oven, oven or in a water bath comprises an outer layer having an energy-absorbing layer in the region defined by the recess of an inner layer and/or in the region surrounding the recess. An independent claim is also included for a film material used for producing the packaging. Preferred Features: Recesses extend from edge to edge of the packaging, preferably only in defined regions of the packaging. A protective seal is provided around the recesses. Intermediate layers, preferably barrier layers, absorber layers or browning layers, are arranged between the inner and outer layers.
Patent CY-1109223-T1 (CY)
Inventor: MACK MICHAEL
IPC: A61K38/18
Filed: 2009-07-17
Abstract: Liquid formulation (I) of granulocyte colony-stimulating factor (G-CSF) comprises G-CSF as an active agent, acetate as a buffer, polysorbate-20 or polysorbate-80 as surfactant and optionally pharmaceutical adjuvants, where the formulation exhibits a pH of 4.1-4.4. An independent claim is included for a process of preparing (I) comprising mixing G-CSF-protein with a solution comprising acetate buffer, polysorbate-20 or polysorbate-80 and optionally pharmaceutical adjuvants. ACTIVITY : Immunostimulant; Antimicrobial. MECHANISM OF ACTION : None given.
Patent CY-1109636-T1 (CY)
Title: Συνθεση στοματικης δοσης παρατεταμενης απελευθερωσης
Inventor: CHO WING-KEE PHILIP
IPC: A61K47/18
Filed: 2009-11-16
Abstract: Αποκαλύπτεται μια συμπιεσμένη διστρωματική στερεά σύνθεση που περιλαμβάνει (α)ένα πρώτο στρώμα άμεσης απελευθέρωσης που περιλαμβάνει μια αντιαλλεργική αποτελεσματική ποσότητα της δεσλοραταδίνης και μια προστατευτική ποσότητα δεσλοραταδίνης ενός φαρμακευτικά αποδεκτού εκδόχου, και (β) ένα δεύτερο στρώμα παρατεταμένης απελευθέρωσης που περιλαμβάνει μια αποτελεσματική ποσότητα ρινικού αποσυμφορητικού παράγοντα όπου η σύνθεση περιλαμβάνει λιγότερο από περίπου 2% προϊόντων αποδόμησης της δεσλοραταδίνης.
Patent CY-1110704-T1 (CY)
Inventor: GARCIA-SASTRE ADOLFO
IPC: C12Q1/70
Filed: 2010-03-16
Abstract: This invention relates to genetically engineered Newcastle disease viruses and viral vectors which express heterologous genes or mutated Newcastle disease viral genes or a combination of viral genes derived from different strains of Newcastle disease virus. The invention relates to the construction and use of recombinant negative strand NDV viral RNA templates which may be used with viral RNA-directed RNA polymerase to express heterologous gene products in appropriate host cells and/or to rescue the heterologous gene in virus particles. In a specific embodiment of the invention, the heterologous gene product is a peptide or protein derived from the genome of a human immunodeficiency virus. The RNA templates of the present invention may be prepared by transcription of appropriate DNA sequences using any DNA-directed RNA polymerase such as bacteriophage T7, T3, SP6 polymerase, or eukaryotic polymerase I.
Patent CY-1111207-T1 (CY)
Inventor: PEANO ROBERTO
IPC: A44B19/34
Filed: 2011-02-16
Abstract: A fluid-tight slide fastener (1) comprising coated tapes (2) carrying respective rows of teeth (3), top and bottom stops (4, 5) and a slider (6), wherein the tapes (2) comprises a knurled region (10) in correspondence of the portion of tapes (2) where said teeth (3) are fixed to the same tapes (2).
Patent CY-1111399-T1 (CY)
Title: Φαρμακο για την υπερδραστηρια ουροδοχο κυστη περιλαμβανον παραγωγο ανιλιδιου οξικου οξεος ως το ενεργο συστατικο
Inventor: TAKASU TOSHIYUKI
IPC: C07D277/40
Filed: 2011-04-18
Abstract: Το ανιλίδιο (R)-2-(2-αμινοθειαζολ-4-υλ)-4'-[2-[(2-υδροξυ-2-φαινυλαιθυλ)αμινο]αιθυλ]οξικού οξέος ή το άλας αυτού εμφανίζει ένα ισχυρό αποτέλεσμα χάλασης της ουροδόχου κύστης σε «δοκιμή χάλασης λείου μυός απομονωμένης ουροδόχου κύστης αρουραίου», μειώνει με δοσοεξαρτώμενο τρόπο τη συχνότητα συστολής των ρυθμικών συστολών ουροδόχου κύστης σε «δοκιμή μέτρησης της ρυθμικής συστολής ουροδόχου κύστης αρουραίου» και, επιπλέον, παρατείνει τα μεσοδιαστήματα ούρησης σε «δοκιμή μέτρησης των λειτουργιών ούρησης σε επαγόμενη από κυκλοφωσφαμίδιο υπερδραστήρια ουροδόχο κύστη μοντέλου αρουραίου». Λόγω αυτών των αποτελεσμάτων, η παραπάνω ένωση είναι χρήσιμη ως ένα φάρμακο για την υπερδραστήρια ουροδόχο κύστη.
Patent CY-1113588-T1 (CY)
Inventor: GARCÍA ARMENTA MARÍA ELENA
IPC: A61P1/04
Filed: 2012-07-24
Abstract: The present invention generally relates to pharmaceutical industry and to drug preparer pharmaceutical industry for prevention and/or treatment of Irritable Bowel Syndrome (IBS) and characteristic symptoms such as abdominal discomfort or pain associated with changes in defecation and frequently abdominal distension, in particular. The present invention, as compared with prior-art compositions for identical purposes, has the following advantages: fewer doses of each one of the active agents, greater speed of action and fewer side effects. The composition that reflects the teachings of the present invention comprises the synergic combination of an L-type calcium-channel blocking agent with selective action on the smooth muscle fiber of the gastrointestinal tract and an antiflatulence agent, and also pharmaceutically acceptable excipients.